Markets:

Overview

News

Currencies

International

Treasuries

PAVmed Inc. - Common Stock (NQ:PAVM)

8.965 +1.215 (+15.68%)

Streaming Delayed Price Updated: 3:06 PM EST, Feb 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about PAVmed Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Which stocks are moving on Friday? ↗

January 23, 2026

Via Chartmill

Which stocks are moving after the closing bell on Wednesday? ↗

January 21, 2026

Via Chartmill

These stocks are moving in today's session ↗

January 21, 2026

Via Chartmill

PAVM Stock Shot Up Over 250% Today – What’s The Deal With The Department of Veterans Affairs? ↗

January 21, 2026

The company’s subsidiary, Lucid Diagnostics, secured a contract from the U.S. Department of Veterans Affairs to provide its EsoGuard Esophageal DNA Test for the detection of esophageal precancer.

Via Stocktwits

Earnings Scheduled For November 13, 2025 ↗

November 13, 2025

Via Benzinga

Earnings Scheduled For August 14, 2025 ↗

August 14, 2025

Via Benzinga

PAVmed's Earnings: A Preview ↗

May 14, 2025

Via Benzinga

Earnings Scheduled For November 13, 2024 ↗

November 13, 2024

Via Benzinga

PAVmed's Earnings: A Preview ↗

November 12, 2024

Via Benzinga

Which stocks are experiencing notable movement on Friday? ↗

January 16, 2026

Via Chartmill

Keep an eye on the top gainers and losers in Friday's session. ↗

January 16, 2026

Via Chartmill

PAVmed Revenue Jumps 513% in Q2 ↗

August 14, 2025

Via The Motley Fool

Topics Intellectual Property

Monday's pre-market session: top gainers and losers ↗

March 31, 2025

Wondering what's happening in Monday's pre-market session? Find an overview in this article.

Via Chartmill

Earnings Scheduled For May 15, 2025 ↗

May 15, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 31, 2025

Via Benzinga

Earnings Scheduled For March 25, 2025 ↗

March 25, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 10, 2025

Via Benzinga

PAVM Stock Earnings: PAVmed Beats EPS, Misses Revenue for Q2 2024 ↗

August 13, 2024

PAVM stock results show that PAVmed beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 17, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 13, 2024

Via Benzinga

PAVM Stock Earnings: PAVmed Beats EPS, Misses Revenue for Q1 2024 ↗

May 14, 2024

PAVM stock results show that PAVmed beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket ↗

April 01, 2024

Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 29, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 29, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 28, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

March 28, 2024

Pre-market stock movers are a hot topic on Thursday as we check out all of the biggest stories moving shares this morning!

Via InvestorPlace

Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 27, 2024

Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fourth-quarter revenue outlook below estimates.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 27, 2024

Via Benzinga

PAVM Stock Earnings: PAVmed Beats EPS, Misses Revenue for Q4 2023 ↗

March 27, 2024

PAVM stock results show that PAVmed beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

Earnings Scheduled For March 26, 2024 ↗

March 26, 2024

Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.